failure to respond or late response
on 05 Jun 2023
Last Applicant/ Owned by
65 Grove Street, Suite 303
Watertown
MA
02472
Serial Number
90273166 filed on 23rd Oct 2020
Registration Number
N/A
Correspondent Address
Roman Fayerberg
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Platelets that are not bone marrow-derived, platelet variants, megakaryocytes, megakaryocytes variants, and products derived from platelets, megakaryocytes or their variants, and admixtures, namely, extracellular vesicles or exosomes, all the foregoing for medical or clinical use; platelet variants for medical or clinical use; pharmaceutical and drug delivery compositions comprising platelet varia Read More
Platelets that are not bone marrow-derived, platelet variants, megakaryocytes, megakaryocytes variants, and products derived from platelets, megakaryocytes or their variants, and admixtures, namely, extracellular vesicles or exosomes, all the foregoing for medical or clinical use; platelet variants for medical or clinical use; pharmaceutical and drug delivery compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; Pharmaceutical compositions for drug delivery comprising non bone marrow-derived platelets, platelet variants for treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; pharmaceutical compositions comprising platelet variants for transfusion in oncology, trauma and surgery; platelet variants for delivering proteins, antibodies, nucleic acids and other drugs to tumors, sites of vascular injury and inflammation, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders, and orthopedics; platelet variants as source for growth factors for medical or clinical use; compositions comprising viral vectors for medical or clinical use
No 90273166
No Service/Collective Mark
No 159224030300
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
06th Jun 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
05th Jun 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
05th Jun 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
15th Oct 2022 | NON-FINAL ACTION WRITTEN |
15th Oct 2022 | NON-FINAL ACTION E-MAILED |
15th Oct 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
13th Apr 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
13th Apr 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
12th Apr 2022 | ASSIGNED TO LIE |
07th Apr 2022 | ASSIGNED TO LIE |